Satellos Bioscience Inc. (MSLE) stock
Close on Nov 12, 2026Market cap $105.58MP/E –Yield –
Satellos Bioscience statistics
53 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Dec 31, 2025
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Share statisticsIndustry
- Shares Change (YoY)
- 52.6%
- 10.9%
- Float
- 15M
- 49M
- Shares Held by Insiders
- 0.00%
- 12.1%
- Shares Held by Institutions
- 49.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 127,108
- –
- Short Interest Change
- 30.7%
- -0.76%
- Short % of Float
- 0.82%
- 9.04%
- Short % of Shares Outstanding
- 0.82%
- 6.30%
- Days to Cover
- 3.86
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $13.39
- –
- 52-Week Low
- $5.30
- –
- 20-Day Moving Average
- $6.69
- –
- 50-Day Moving Average
- $7.82
- –
- 200-Day Moving Average
- $8.36
- –
- Average True Range (14)
- $0.55
- –
- Price Change (1 Week)
- 7.56%
- 1.51%
- Price Change (1 Month)
- 3.02%
- -2.35%
- Price Change (3 Months)
- -28.9%
- -21.1%
- Price Change (6 Months)
- -4.74%
- -22.6%
- Price Change (YTD)
- 16.2%
- -22.6%
- Price Change (1 Year)
- 11.1%
- -20.7%
- Price Change (3 Years)
- 147.5%
- -27.4%
- Price Change (5 Years)
- -49.5%
- -77.3%
- Price Change (10 Years)
- -5.14%
- -62.7%
- Average Volume (10 Days)
- 59,494
- –
- Average Volume (20 Days)
- 46,458
- –
- Average Volume (90 Days)
- 51,961
- –
- Relative Volume
- 1.00
- 0.79
- Relative Strength Index (14)
- 46.6
- 44.7
- Volatility (1 Year)
- 83.3%
- 80.4%
- Beta (5 Years)
- 3.39
- 1.07
Returns on capitalIndustry
- Return on Capital Employed (ROCE)
- -95.2%
- -38.0%
Financial positionIndustry
- Current Ratio
- 7.77
- 3.30
- Quick Ratio
- 2.39
- 2.42
EfficiencyIndustry
- WACC
- 17.5%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$24.70M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $9.80M
- $17.46M
- Net Cash Per Share
- $0.63
- $0.72
- Working Capital
- $27.78M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$6.00K
- -$944.00K
- FCF Per Share
- -$1.53
- -$0.42
Dividends and yieldsIndustry
- FCF Yield
- -22.4%
- -9.58%
Taxes and interestIndustry
- Income Tax
- $172.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 10.14
- 0.30
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | MSLE | S&P 500 | Difference | MSLE per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.7% | -2.7% | −2.0 pts | ||
| 3 months | -31.8% | -1.7% | −30.1 pts | ||
| Year to date | +16.2% | +11.9% | +4.3 pts | ||
| 1 year | +13.8% | +12.0% | +1.8 pts | ||
| 3 years | +158.2% | +78.2% | +80.0 pts | +37.2% | +21.2% |
| 5 years | -49.5% | +73.2% | −122.7 pts | -12.8% | +11.6% |
| 10 years | -5.1% | +309.6% | −314.8 pts | -0.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M MSLE shares were sold short on Oct 30, 2026, up 30.7% from the previous report, or 0.82% of the shares available to trade. At recent volumes it would take 3.9 days to buy them back. Over the last 20 sessions, 45.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 127,108 | +30.7% | 32,942 | 3.9 |
| Oct 15, 2026 | 97,288 | -7.9% | 61,077 | 1.6 |
| Sep 30, 2026 | 105,687 | +28.2% | 66,735 | 1.6 |
| Sep 15, 2026 | 82,427 | -7.5% | 31,945 | 2.6 |
| Aug 31, 2026 | 89,063 | -2.8% | 20,830 | 4.3 |
| Aug 14, 2026 | 91,665 | -19.0% | 27,134 | 3.4 |
| Jul 31, 2026 | 113,110 | +8.7% | 66,814 | 1.7 |
| Jul 15, 2026 | 104,097 | +24.7% | 123,155 | 1.0 |
| Jun 30, 2026 | 83,488 | +18.9% | 48,100 | 1.7 |
| Jun 15, 2026 | 70,188 | -8.6% | 36,542 | 1.9 |
| May 29, 2026 | 76,818 | -9.5% | 25,605 | 3.0 |
| May 15, 2026 | 84,855 | -11.4% | 33,380 | 2.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?